Virtual care has its gaps - it’s time we talked about it
For this piece, we wanted to get a deeper industry perspective. So we teamed up with Omada Health CEO Sean Duffy. If you haven’t heard of Omada, it’s one of the OG digital health companies that started out in preventing diabetes and now works across diabetes, hypertension and more. So this analysis represents both of our views.
As an industry, we all talk a lot about virtual-first care. But let’s get real. Telemedicine and remote care have limits. There are times when it works extremely well. And there are times when the patient needs to be seen in person.
We all know that to be true on a deeper level. And yet, we wondered if there would be a way to actually quantify that. How much of our care services could be administered in a virtual setting and what type of treatment needs to stay brick and mortar? And how will that ratio change in the future - and why? As we move from hype to balance, we think that the real work lies ahead. Both ambulatory care managers and new digital entrants alike need to think through the right balance between virtual and in-person.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
AMA with Doximity CEO Jeff Tangney
Join Doximity CEO Jeff Tangney for a live Q&A on where clinicians are finding value with AI, how Doximity has evolved, and building a company from zero to IPO.
Office Hours
A live Q&A with Christina Farr and Ruth Reader, exclusively for Second Opinion Premium members. Thursday, November 19, 1:30–2:30 p.m. ET / 10:30–11:30 a.m. PT.
The Shift Left & the Impact of the Midterms on Healthcare
Democrats just took both chambers. Aneesh Chopra, Christopher Kerns and Mike Desjadon join Ruth Reader and Christina Farr live to talk through what they'll try to do on healthcare — and what's actually achievable under a Republican White House.
Is It Finally the Moment for Alternative Health Plans?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&